Back to Search Start Over

Pancreatic neuroendocrine neoplasms

Pancreatic neuroendocrine neoplasms

Authors :
T D Poeppel
A Sabet
H Lahner
Thomas C. Lauenstein
K Beiderwellen
Source :
Der Radiologe. 56:348-354
Publication Year :
2016
Publisher :
Springer Science and Business Media LLC, 2016.

Abstract

Pancreatic neuroendocrine neoplasms (NEN) account for 1-2% of all pancreatic neoplasms and represent a rare differential diagnosis. While some pancreatic NEN are hormonally active and exhibit endocrine activity associated with characteristic symptoms, the majority are hormonally inactive. Imaging techniques such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) or as combined PET/CT play a crucial role in the initial diagnosis, therapy planning and control. Endoscopic ultrasound (EUS) and multiphase CT represent the reference methods for localization of the primary pancreatic tumor. Particularly in the evaluation of small liver lesions MRI is the method of choice. Somatostatin receptor scintigraphy and somatostatin receptor PET/CT are of particular value for whole body staging and special aspects of further therapy planning.

Details

ISSN :
14322102 and 0033832X
Volume :
56
Database :
OpenAIRE
Journal :
Der Radiologe
Accession number :
edsair.doi.dedup.....2769f63a7b50e1108cbcc806a7a0e065
Full Text :
https://doi.org/10.1007/s00117-016-0094-x